First patient receives controversial Biogen Alzheimer’s drug
Published
A US hospital on Wednesday gave the first infusion of an expensive, controversial new Alzheimer’s drug from Biogen.
Full ArticlePublished
A US hospital on Wednesday gave the first infusion of an expensive, controversial new Alzheimer’s drug from Biogen.
Full Article4.10pm Nasdaq closes at record high once again Wall Street as a whole ended mixed on Wednesday but the Nasdaq saw another record..
Watch VideoGovernment health officials on Monday approved the first new drug for Alzheimer's disease in nearly 20 years,..